179 related articles for article (PubMed ID: 37307420)
1. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Sehgal P; Su S; Zech J; Nobel Y; Luk L; Economou I; Shen B; Lewis JD; Freedberg DE
Inflamm Bowel Dis; 2024 Apr; 30(4):594-601. PubMed ID: 37307420
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.
Uko V; Vortia E; Achkar JP; Karakas P; Fiocchi C; Worley S; Kay MH
Inflamm Bowel Dis; 2014 Dec; 20(12):2286-91. PubMed ID: 25222655
[TBL] [Abstract][Full Text] [Related]
4. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Yarur AJ; Bruss A; Moosreiner A; Beniwal-Patel P; Nunez L; Berens B; Colombel JF; Targan SR; Fox C; Melmed GY; Abreu MT; Deepak P
Gastroenterology; 2023 Oct; 165(4):963-975.e5. PubMed ID: 37499955
[TBL] [Abstract][Full Text] [Related]
5. Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease.
Harper JW; Sinanan MN; Zisman TL
Inflamm Bowel Dis; 2013 Sep; 19(10):2118-24. PubMed ID: 23863401
[TBL] [Abstract][Full Text] [Related]
6. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Gu P; Chhabra A; Chittajallu P; Chang C; Mendez D; Gilman A; Fudman DI; Xi Y; Feagins LA
Inflamm Bowel Dis; 2022 May; 28(5):657-666. PubMed ID: 34291800
[TBL] [Abstract][Full Text] [Related]
7. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease.
Zhou Z; Xiong Z; Cheng R; Luo Q; Li Y; Xie Q; Xiao P; Hu D; Hu X; Shen Y; Li Z
Eur Radiol; 2023 Mar; 33(3):1862-1872. PubMed ID: 36255487
[TBL] [Abstract][Full Text] [Related]
8. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
[TBL] [Abstract][Full Text] [Related]
9. CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.
Zeng Q; Wang L; Dong S; Zha X; Ran L; Li Y; Chen S; Gao J; Li S; Lu Y; Zhang Y; Xiao X; Li Y; Ma X; Gong X; Chen W; Yang Y; Du X; Chen B; Lv Y; Wu Y; Hong G; Pan Y; Jiao J; Yan Y; Qi H; Zhai J; Li K; Zhao K; Wu J; Liu S; Blake GM; Fu H; Fu X; Guo Z; Lemieux I; Després JP; Cheng X;
Metabolism; 2021 Feb; 115():154456. PubMed ID: 33259834
[TBL] [Abstract][Full Text] [Related]
10. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
Lee CG; Lee JK; Kang YS; Shin S; Kim JH; Lim YJ; Koh MS; Lee JH; Kang HW
Am J Gastroenterol; 2015 Feb; 110(2):310-9. PubMed ID: 25583325
[TBL] [Abstract][Full Text] [Related]
11. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
[TBL] [Abstract][Full Text] [Related]
12. Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia.
Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman SN; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200405
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.
Bidulescu A; Liu J; Hickson DA; Hairston KG; Fox ER; Arnett DK; Sumner AE; Taylor HA; Gibbons GH
BMC Cardiovasc Disord; 2013 Feb; 13():9. PubMed ID: 23433085
[TBL] [Abstract][Full Text] [Related]
14. Lower Subcutaneous or Visceral Adiposity Assessed by Abdominal Computed Tomography Could Predict Adverse Outcome in Patients With Crohn's Disease.
Thiberge C; Charpentier C; Gillibert A; Modzelewski R; Dacher JN; Savoye G; Savoye-Collet C
J Crohns Colitis; 2018 Nov; 12(12):1429-1437. PubMed ID: 30260374
[TBL] [Abstract][Full Text] [Related]
15. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
[TBL] [Abstract][Full Text] [Related]
16. Associations of adult genetic risk scores for adiposity with childhood abdominal, liver and pericardial fat assessed by magnetic resonance imaging.
Monnereau C; Santos S; van der Lugt A; Jaddoe VWV; Felix JF
Int J Obes (Lond); 2018 Apr; 42(4):897-904. PubMed ID: 29437161
[TBL] [Abstract][Full Text] [Related]
17. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma.
Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
Int J Cancer; 2014 Nov; 135(10):2273-81. PubMed ID: 24692064
[TBL] [Abstract][Full Text] [Related]
18. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by
Rivers JP; Powell-Wiley TM; Dey AK; Rodante JA; Chung JH; Joshi AA; Natarajan B; Sajja AP; Chaturvedi A; Rana A; Harrington CL; Teague HL; Lockshin BN; Ahlman MA; Yao J; Playford MP; Gelfand JM; Mehta NN
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):349-357. PubMed ID: 29055628
[TBL] [Abstract][Full Text] [Related]
19. Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease.
Sekine K; Nagata N; Sakamoto K; Arai T; Shimbo T; Shinozaki M; Okubo H; Watanabe K; Imbe K; Mikami S; Nozaki Y; Sakurai T; Yokoi C; Kojima Y; Kobayakawa M; Yanase M; Akiyama J; Noda M; Uemura N
J Gastroenterol Hepatol; 2015 Aug; 30(8):1325-31. PubMed ID: 25869941
[TBL] [Abstract][Full Text] [Related]
20. Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
Fukushima T; Maetani T; Chubachi S; Tanabe N; Asakura T; Namkoong H; Tanaka H; Shimada T; Azekawa S; Otake S; Nakagawara K; Watase M; Shiraishi Y; Terai H; Sasaki M; Ueda S; Kato Y; Harada N; Suzuki S; Yoshida S; Tateno H; Yamada Y; Jinzaki M; Hirai T; Okada Y; Koike R; Ishii M; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
Metabolism; 2024 Jan; 150():155715. PubMed ID: 37918794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
